Security Snapshot

DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) Institutional Ownership

CUSIP: 256135203

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

243

Shares (Excl. Options)

120,321,425

Price

$13.85

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Type / Class
Equity / American depositary shares, each representing one equity share
Symbol
RDY on NYSE
Shares outstanding
834,731,296
Price per share
$13.73
All holders as of 31 Mar 2026
Q1 2026
Total 13F shares
120,321,425
Total reported value
$1,664,927,512
% of total 13F portfolios
0%
Share change
+14,835,254
Value change
+$205,955,198
Number of holders
243
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • RDY - DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share is tracked under CUSIP 256135203.
  • 243 institutions reported positions in Q1 2026.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 234 to 243 between Q4 2025 and Q1 2026.
  • Reported value moved from $1,495,864,652 to $1,664,927,512.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 243 institutions filings for Q1 2026.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 256135203?
CUSIP 256135203 identifies RDY - DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q1 2026 holders report and the ownership history table below.

Significant Owners of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Prasad G V 14% $1,607,395,312 113,356,510 K. Satish Reddy 17 Sep 2025

As of 31 Mar 2026, 243 institutional investors reported holding 120,321,425 shares of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY). This represents 14% of the company’s total 834,731,296 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) together control 13% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Robeco Institutional Asset Management B.V. 2.1% 17,177,882 +31% 0.34% $237,913,669
BlackRock, Inc. 1.4% 11,587,127 +13% 0% $160,481,704
ROYAL BANK OF CANADA 1.2% 9,984,081 +4.6% 0.03% $138,293,000
MORGAN STANLEY 1.1% 9,371,594 +5% 0.01% $129,796,619
Aikya Investment Management Ltd 0.96% 7,999,796 +9% 32% $110,797,175
RENAISSANCE TECHNOLOGIES LLC 0.94% 7,859,728 -4.8% 0.17% $108,857,233
DIMENSIONAL FUND ADVISORS LP 0.64% 5,323,248 -0.63% 0.02% $73,667,799
JPMORGAN CHASE & CO 0.52% 4,371,378 -20% 0% $58,838,753
STATE STREET CORP 0.48% 4,026,207 +0.93% 0% $55,762,967
BNP PARIBAS FINANCIAL MARKETS 0.38% 3,183,971 0% 0.03% $44,097,998
VANGUARD CAPITAL MANAGEMENT LLC 0.37% 3,100,911 0% 0% $42,947,617
FRANKLIN RESOURCES INC 0.34% 2,856,094 0.01% $39,556,903
MARSHALL WACE, LLP 0.32% 2,664,306 +416% 0.04% $36,900,638
ALLIANCEBERNSTEIN L.P. 0.3% 2,541,889 +8384% 0.01% $35,688,122
ACADIAN ASSET MANAGEMENT LLC 0.29% 2,408,761 +12% 0.05% $33,352,000
BESSEMER GROUP INC 0.22% 1,823,285 +28% 0.04% $25,253,000
VANGUARD PORTFOLIO MANAGEMENT LLC 0.21% 1,773,738 0% 0% $24,566,271
AMERICAN CENTURY COMPANIES INC 0.2% 1,661,333 +23% 0.01% $23,009,462
UBS Group AG 0.19% 1,552,308 +57% 0% $21,499,466
Creative Planning 0.14% 1,167,182 +0.42% 0.01% $16,165,465
NORTHERN TRUST CORP 0.13% 1,089,329 -0.07% 0% $15,087,206
LAZARD ASSET MANAGEMENT LLC 0.13% 1,059,831 -9.3% 0.02% $14,678,659
Quantinno Capital Management LP 0.08% 637,094 +71% 0.01% $8,823,765
GOLDMAN SACHS GROUP INC 0.07% 602,836 +89% 0% $8,349,273
NEW YORK STATE COMMON RETIREMENT FUND 0.07% 588,706 0.01% $8,153,578

Institutional Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 120,321,425 $1,664,927,512 +$205,955,198 $13.85 243
2025 Q4 106,545,966 $1,495,864,652 -$7,926,548 $14.04 234
2025 Q3 107,044,315 $1,496,471,323 -$18,825,882 $13.98 227
2025 Q2 107,490,178 $1,615,554,376 -$2,437,828 $15.03 239
2025 Q1 109,568,130 $1,445,145,982 -$147,804,573 $13.19 239
2024 Q4 118,585,675 $1,871,315,562 +$1,379,421,949 $15.79 246
2024 Q3 22,323,793 $1,773,509,164 -$32,845,620 $79.45 219
2024 Q2 24,129,104 $1,838,811,719 +$25,813,649 $76.19 221
2024 Q1 23,624,631 $1,732,414,047 +$4,316,081 $73.35 230
2023 Q4 23,549,346 $1,638,068,047 -$19,538,179 $69.58 223
2023 Q3 22,552,672 $1,508,022,257 +$123,782,702 $66.87 212
2023 Q2 20,723,050 $1,307,742,762 +$121,928,914 $63.11 191
2023 Q1 18,804,291 $1,070,382,001 +$136,751,438 $56.93 187
2022 Q4 16,423,176 $849,847,851 +$3,224,170 $51.75 160
2022 Q3 16,349,824 $856,712,431 +$35,896,390 $52.34 147
2022 Q2 15,653,996 $866,231,781 -$30,425,047 $55.39 148
2022 Q1 16,608,544 $923,504,810 +$4,920,142 $55.73 144
2021 Q4 16,496,810 $1,073,027,505 -$47,497,883 $65.41 141
2021 Q3 16,964,108 $1,105,536,697 -$93,370,525 $65.14 142
2021 Q2 18,379,985 $1,350,931,522 +$10,457,878 $73.51 156
2021 Q1 18,276,597 $1,128,117,710 -$17,322,858 $61.39 159
2020 Q4 19,125,629 $1,364,282,518 -$153,956,523 $71.29 170
2020 Q3 21,329,258 $1,481,500,793 -$17,904,382 $69.56 183
2020 Q2 21,616,772 $1,145,533,854 +$16,564,346 $53.01 167
2020 Q1 21,329,368 $861,309,678 -$4,218,038 $40.33 143
2019 Q4 21,438,572 $870,084,792 +$18,200,719 $40.58 143
2019 Q3 20,985,453 $795,412,395 -$26,186,555 $37.89 148
2019 Q2 21,654,714 $811,493,463 +$17,752,465 $37.47 146
2019 Q1 21,145,526 $856,437,692 +$30,798,825 $40.50 141
2018 Q4 20,415,214 $769,607,321 +$59,512,518 $37.70 142
2018 Q3 18,900,291 $650,214,052 -$43,956,397 $34.60 122
2018 Q2 20,321,786 $654,386,435 -$49,621,742 $32.20 130
2018 Q1 21,776,595 $711,493,019 +$108,057 $32.69 119
2017 Q4 21,751,667 $816,953,752 -$37,479,890 $37.56 116
2017 Q3 22,729,401 $811,012,307 -$95,718,487 $35.68 116
2017 Q2 25,280,563 $1,065,074,046 +$13,001,072 $42.14 127
2017 Q1 24,998,986 $1,003,880,481 -$48,350,770 $40.15 132
2016 Q4 27,315,628 $1,237,695,092 +$11,132,499 $45.28 161
2016 Q3 26,671,789 $1,238,813,813 -$11,598,960 $46.42 154
2016 Q2 26,837,854 $1,392,008,743 -$12,404,048 $51.23 155
2016 Q1 26,892,330 $1,220,577,828 -$88,233,808 $45.19 157
2015 Q4 28,820,386 $1,337,495,830 +$25,681,228 $46.29 169
2015 Q3 28,014,528 $1,789,938,205 +$197,320,692 $63.91 201
2015 Q2 24,973,479 $1,381,318,862 +$28,786,696 $55.32 186
2015 Q1 24,488,756 $1,395,870,125 -$54,865,208 $57.10 170
2014 Q4 25,475,072 $1,284,844,060 +$45,980,275 $50.45 164
2014 Q3 24,234,657 $1,273,510,655 -$18,359,585 $52.55 157
2014 Q2 25,553,686 $1,103,106,351 +$52,687,519 $43.15 167
2014 Q1 24,299,894 $1,065,961,113 +$91,925,526 $43.90 164
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .